BioMarin Pharmaceutical Inc. buy Wells Fargo & Company
Start price
15.11.23
/
50%
€80.32
Target price
15.11.24
€92.05
Performance (%)
-24.98%
End price
16.11.24
€60.26
Summary
This prediction ended on 16.11.24 with a price of €60.26. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -24.98%. Wells_Fargo___Compan has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.259% | -0.259% | -26.951% |
| iShares Core DAX® | 1.659% | 1.586% | 18.113% |
| iShares Nasdaq 100 | 0.381% | 1.900% | 8.877% |
| iShares Nikkei 225® | 2.102% | -1.377% | 13.281% |
| iShares S&P 500 | 0.221% | 1.258% | 3.556% |
Comments by Wells_Fargo___Compan for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $100.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.07
28.10.25
28.10.25
€60.05
28.10.26
28.10.26
0.37%
09.12.25
09.12.25
Stopped prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€64.04
17.09.24
17.09.24
€80.92
17.09.25
17.09.25
-27.97%
18.09.25
18.09.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.46
27.06.24
27.06.24
€107.36
27.06.25
27.06.25
-39.27%
28.06.25
28.06.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.00
25.04.24
25.04.24
€102.63
25.04.25
25.04.25
-27.92%
26.04.25
26.04.25